Alzheimer's disease: Molecular genetics and transgenic animal models

[1]  G. Casadesus,et al.  Animal Models of Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[2]  L. Lannfelt,et al.  No linkage to chromosome 14 in Swedish Alzheimer's disease families , 1993, Nature Genetics.

[3]  J. Loring,et al.  Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome , 1993, Nature Genetics.

[4]  C. Higgins,et al.  Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy , 1993, Nature.

[5]  G. Kelsey,et al.  A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice , 1993, Nature.

[6]  L. Green,et al.  Germ-line transmission and expression of a human-derived yeast artificial chromosome , 1993, Nature.

[7]  D. Melton,et al.  Production of a model for Lesch–Nyhan syndrome in hypoxanthine phosphoribosyltransferase–deficient mice , 1993, Nature Genetics.

[8]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[9]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[10]  J. Hardy,et al.  A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene , 1992, Nature Genetics.

[11]  C. Broeckhoven,et al.  Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3 , 1992, Nature Genetics.

[12]  D. Pollen,et al.  Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14 , 1992, Nature Genetics.

[13]  J. Weber,et al.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.

[14]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[15]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.

[16]  J. Hardy,et al.  Framing β–amyloid , 1992, Nature Genetics.

[17]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[18]  G. Higgins,et al.  Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein , 1992, Nature.

[19]  F. Fonnum,et al.  Persistent changes in behaviour and brain serotonin during ageing in rats subjected to infant nasal virus infection , 1992, Neurobiology of Aging.

[20]  N. Lindefors,et al.  Widespread neuronal degeneration after ibotenic acid lesioning of cholinergic neurons in the nucleus basalis revealed by in situ hybridization , 1992, Neuroscience Letters.

[21]  S. Zain,et al.  Expression of the human beta-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice. , 1991, Journal of Biological Chemistry.

[22]  Stephen B. Dunnett,et al.  The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions , 1991, Trends in Neurosciences.

[23]  S. Hirai,et al.  Expression of APP in the early stage of brain damage , 1991, Brain Research.

[24]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[25]  B. Ghetti,et al.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.

[26]  M. Vitek,et al.  Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer's disease and normal brain by S1 nuclease protection analysis , 1991, Neurobiology of Aging.

[27]  B. Trapp,et al.  Deposits of amyloid beta protein in the central nervous system of transgenic mice. , 1991, Science.

[28]  K. Murakami,et al.  Formation of β-amyloid protein deposits in brains of transgenic mice , 1991, Nature.

[29]  H. Fibiger.  Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence , 1991, Trends in Neurosciences.

[30]  R. Tanzi,et al.  Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells , 1991, Neuroscience Letters.

[31]  R. Tanzi,et al.  Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex , 1991, Neuroscience Letters.

[32]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[33]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[34]  B. Trapp,et al.  Regulatory region of human amyloid precursor protein (APP) gene promotes neuron‐specific gene expression in the CNS of transgenic mice. , 1991, The EMBO journal.

[35]  S. Prusiner,et al.  Spontaneous neurodegeneration in transgenic mice with mutant prion protein , 1990, Science.

[36]  C. Finch,et al.  Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.

[37]  G. Buzsáki,et al.  Nucleus basalis lesions fail to induce senile plaques in the rat , 1990, Experimental Neurology.

[38]  G. Glenner,et al.  Amyloidosis of the nervous system , 1989, Journal of the Neurological Sciences.

[39]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  David M. A. Mann,et al.  Cerebral amyloidosis, ageing and Alzheimer's disease; A contribution from studies on Down's syndrome , 1989, Neurobiology of Aging.

[41]  R. Martins,et al.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[42]  Jurg Ott,et al.  Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome , 1989, Nature.

[43]  R. Bartus.  The need for common perspectives in the development and use of animal models for age-related cognitive and neurodegenerative disorders , 1988, Neurobiology of Aging.

[44]  D. Price,et al.  Neurofibrillary Tangles and Senile Plaques in Aged Bears , 1988, Journal of neuropathology and experimental neurology.

[45]  S. M. Sumi,et al.  Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. , 1988, Science.

[46]  S. Shiojiri,et al.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.

[47]  L. Villa-komaroff,et al.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease , 1988, Nature.

[48]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.

[49]  W. Millard,et al.  Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. , 1987, Science.

[50]  C. Broeckhoven,et al.  Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families , 1987, Nature.

[51]  J. Haines,et al.  The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein gene , 1987, Nature.

[52]  J. Morrison,et al.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. , 1987, Science.

[53]  D. Price,et al.  Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. , 1987, Science.

[54]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[55]  B. Winblad,et al.  Transmitter deficits in Alzheimer's disease , 1985, Neurochemistry International.

[56]  J. Morrison,et al.  Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  G K Wilcock,et al.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[58]  H. Wiśniewski,et al.  NEURITIC (SENILE) PLAQUES AND FILAMENTOUS CHANGES IN AGED RHESUS MONKEYS , 1973, Journal of neuropathology and experimental neurology.

[59]  H. Wiśniewski,et al.  Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[60]  W. K. Parker,et al.  MORPHOLOGY , 1954, Computer Vision.

[61]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[62]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors , 1988 .

[63]  S. Prusiner.  Prions causing degenerative neurological diseases. , 1987, Annual review of medicine.